Compare BANX & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BANX | MYO |
|---|---|---|
| Founded | 2013 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.8M | 33.2M |
| IPO Year | N/A | 2017 |
| Metric | BANX | MYO |
|---|---|---|
| Price | $22.43 | $1.03 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.67 |
| AVG Volume (30 Days) | 23.4K | ★ 760.2K |
| Earning Date | 06-17-2025 | 11-10-2025 |
| Dividend Yield | ★ 9.66% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.35 | N/A |
| Revenue | $29,467,794.00 | ★ $41,643,203.00 |
| Revenue This Year | N/A | $24.07 |
| Revenue Next Year | N/A | $17.48 |
| P/E Ratio | $8.88 | ★ N/A |
| Revenue Growth | 2.73 | ★ 65.00 |
| 52 Week Low | $17.99 | $0.71 |
| 52 Week High | $21.67 | $7.17 |
| Indicator | BANX | MYO |
|---|---|---|
| Relative Strength Index (RSI) | 60.89 | 54.20 |
| Support Level | $22.06 | $0.91 |
| Resistance Level | $22.50 | $1.02 |
| Average True Range (ATR) | 0.29 | 0.08 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 90.00 | 45.04 |
ArrowMark Financial Corp is a non-diversified, closed-end management investment company. Its objective is to provide stockholders with current income, and to a lesser extent capital appreciation. The company's investments in various portfolios such as debt securities, Trust Preferred and Preferred Securities, preferred securities, exchange-traded funds, money market funds and others.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).